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Edited by Maurice MontalAbstract Cry1Ab is one of the most studied insecticidal
proteins produced by Bacillus thuringiensis during sporulation.
Structurally, this protoxin has been divided in two domains: the
N-terminal toxin core and the C-terminal portion. Although
many studies have addressed the biochemical characteristics of
the active toxin that corresponds to the N-terminal portion, there
are just few reports studying the importance of the C-terminal
part of the protoxin. Herein, we show that Cry1Ab protoxin has
a unique natural cryptic endotoxic property that is evident when
their halves are expressed individually. This toxic eﬀect of the
separate protoxin domains was found against its original host B.
thuringiensis, as well as to two other bacteria, Escherichia coli
and Agrobacterium tumefaciens. Interestingly, either the fusion
of the C-terminal portion with the insecticidal domain-III or the
whole N-terminal region reduced or neutralized such a toxic
eﬀect, while a non-Cry1A peptide such as maltose binding
protein did not neutralize the toxic eﬀect. Furthermore, the C-
terminal domain, in addition to being essential for crystal
formation and solubility, plays a crucial role in neutralizing the
toxicity caused by a separate expression of the insecticidal
domain much like a dot/anti-dot system.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Bacillus thuringiensis1. Introduction
Bacillus thuringiensis is a gram-positive soil bacterium that
forms parasporal crystals during sporulation that are mainly
composed of one of several insecticidal proteins highly speciﬁc
for diﬀerent insect larvae and nematodes [1,2]. These insecti-
cidal toxins form a large family of out-inside ionic channels
with more than a hundred members described so far [3,4]. The
mode of action of B. thuringiensis toxin could be summarized
in four steps: (i) crystal solubilization in the insect’s midgut, (ii)
proteolysis of the protoxins to yield toxins, (iii) binding of* Corresponding authors. Fax: +305-243-5636.
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doi:10.1016/j.febslet.2004.06.021toxins to a receptor and then, ion channel formation on co-
lumnar cells, and (iv) osmotic dysfunction of the insect’s in-
testinal epithelium [3,5].
The bipyramidal crystals, formed by Cry1A protoxins of
120–140 kDa, have been extensively studied during past de-
cades. These bodies are soluble into high pH and produce 70
kDa toxins upon trypsinization [6,7]. The 3-D structure of the
Cry1Aa toxin showed a conserved three-domain conﬁguration
(domains I, II and III), which seems to be essential for the lytic
activity [8]. Although the spatial structure of Cry1A protoxins
is not yet determined, it has been divided in two portions: the
N-terminal containing the insecticidal toxin and the C-termi-
nal, whose function is still not well understood [9,10]. The N-
terminal half of the protoxin is predominantly hydrophobic
whereas the C-terminal half is hydrophilic. C-terminal halves
of the Cry1A molecules contain 14 of the total 16 cysteines and
31 of the total 34 protoxin lysines. The thiol groups of the
solubilized crystal protein are exposed on the surface of the
molecule, and the disulﬁde bonds stabilize the crystal structure
[11].
Interestingly, the C-terminal half of Cry1A primary struc-
ture is highly conserved among the related crystal proteins
[12,13]. Whether this sequence conservation reﬂects an essen-
tial structural requirement for crystal formation and/or a re-
quirement for correct folding of the N-terminal toxic moiety is
unclear. Recently, reports have provided clues for a possible
role of this domain in the protoxin’s biological properties. For
example, chimeric protoxins produced by exchange of C-ter-
minal portions between Cry1Ab and Cry1C became more ef-
fective against Spodoptera exigua [14]. Other authors reported
that mutations in the primary sequence of the C-terminal
portion of the Cry1Ab protoxin could aﬀect the solubility of
inclusion bodies [15]. On the other hand, the replacement of
one cysteine of the native Cry1Ab C-terminal by a heteroge-
neous sequence, aﬀected the formation of crystals. The latter
supports the hypothesis that the cysteine-rich C-terminal
halves of Cry1 proteins are essential for crystallization [16].
Up till now, the C-terminal half of Cry1A has been known
as deprived of any toxicity and is digested by midgut proteases
right after solubilization. Herein, we report a cryptic endotoxic
character of B. thuringiensis Cry1Ab insecticidal crystal pro-
tein. The individual expression of either the insecticidal or
crystal domain in B. thuringiensis carried out lethal eﬀects on
its growth. In contrast with the N-terminal insecticidalation of European Biochemical Societies.
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highly toxic to Escherchia coli and Agrobacterium tumefaciens.
In spite of this toxicity, the complete protoxin was harmless.
The toxicity of the C-terminal portion was also reduced or
neutralized when a C-terminal was fused to domain III of the
insecticidal N-terminal domain.2. Materials and methods
2.1. Bacterial strains and culture media
Escherchia coli XL-1 Blue (Stratagene, CA) cells were grown in LB
medium supplemented with ampicillin at 100 mg/L at 37 C [17].
A. tumefaciens PGV 2260 bacteria were directly transformed according
with Holster et al. [18] and selected on YEB medium supplemented
with rifampicin at 50 mg/L, carbenicillin at 50 mg/L, ampicillin at 100
mg/L, kanamycin 100 mg/L at 28 C. Acrystalliferous B. thuringiensis
subspecies israelensis cry bacteria were transformed by electropora-
tion [19], and positive cells grown on solid LB medium supplemented
with erythromycin at 25 mg/L. The GYS sporulation medium [0.1%
glucose, 0.2% yeast extract, 0.05% K2HPO4, 0.2% (NH4)2SO4, 0.002%
MgSO4, 0.005% MnSO4, and 0.008% CaCl2] was used for growth
curve and viability determinations [20].
2.2. Recombinant plasmid constructs
All genetic constructs are represented in Fig. 1. The 3 kb DNA
fragment containing the C-terminal portion of cry1Ab gene (cry1Ab
cter) was isolated by PCR from pOS 4403 plasmid, donated by Dr.
Donald Dean, University of Ohio [21], using the following primers: 50
gaggatccaggcctgcagaagtaacctttgag 30 (homologous to +1816 position
into the cry1Ab gene) and 50 ctgtgactggtgagtactcaaccaagg 30 (inside of
ampicillin resistant gene). Subsequently, the BamHI–PstI-digested
amplicon (2064 pb) was inserted into pBlueScrip SK (+) plasmid to
produce the pBS-cry1Ab-cter, and sequencing was determined by the
dideoxynucleotide-based method. The pCons 36 and pMal-ter plas-
mids were generated by inserting the BamHI–PstI cry1Ab-cter gene
segment into the pQE-30 (Qiagen, CA) and pMal-p2 (NE Biolabs,
ME) expression vectors. Additionally, a 2.6 Kb SacI–PstI DNA seg-
ment containing the domain III of the insecticidal toxin together with
its C-terminal portion, was isolated from pOS4403 and inserted into
the pQE-30. The resulting plasmid was named pCons SP. Re-
combinant expression of the Cry1Ab C-terminal protein fused to
maltose binding protein (MBP) in A. tumefaciens was carried out with
the pGTox plasmid generated by insertion of a 3.6 kb Fsp I DNA
fragment from pMal-ter into the SmaI site of binary vector pCAMBIA
1301 (http://www.cambia.org/). This DNA fragment contained bothFig. 1. Diagram of the genetic constructs used in this study. All genes
expressed in B. thuringiensis were under the control of cry1Ac pro-
moter in pLBA-100 plasmid. Genes expressed in E. coli were under the
control of Ptac promoter except for pUCK-19, where the Plac pro-
moter was used instead.the mbp-cry1Ab-cter gene and the lacIQ repressor. For recombinant
gene expression in B. thuringiensis, the binary plasmid pLBA-100 was
constructed as follows: Brieﬂy, the promoter and transcriptional ter-
minator regions of cry1Ac gene were ampliﬁed from B. thuringiensis
HD-73 total DNA using 50-aaggtgaattccaggtaaatggttctaac-30 (forward)
and 50-gatagaattcctccatctcttttattaag-30 (reverse) as primers for the
promoter, and 50-ctcaagcttactcaggtttaaatatcg-30 (forward) and 50-
ttcaagcttcaaaaacatcctattt-30 (reverse) as primers for the terminator.
The cry1Ac gene terminator and promoter regions were inserted, re-
spectively, into the HindIII and EcoRI sites of pTH304 binary vector,
donated by Dr. Didier Lereclus from Institut Pasteur, Paris [22].
Subsequently, the following plasmids were made using the pLBA-100:
(1) pLBA-tCry1Ab by insertion of BamHI fragment from pUCK19
[23]; (2) pLBA-Cry1Ab-cter by insertion of SmaI–BamHI cry1Ab-cter
fragment from pBS-cry1Ab-cter; (3) pLBA-Cry1Ab by insertion of
BamHI cry1Ab gene from pOS 4403; and (4) pLBA-SP by insertion of
SacI–PstI fragment from pCons-SP. Finally, the cry1ab-cter gene was
split in two by HindIII digestion of pCons36 plasmid to generate the
pCons DHindIII and pCons HindIII.
2.3. Growth curves and viability assays
Individual colonies were grown separately overnight in 2 ml of the
medium supplemented with antibiotics. Next day, fresh cultures were
re-inoculated and grown to a cell density of 0.4 OD. At this point,
IPTG was added to a ﬁnal concentration of 1 mM for induction of
recombinant protein expression in E. coli and A. Tumefaciens. The
IPTG is not required for protein expression in B. thuringiensis cells.
OD readings (OD 600 nm), viability and protein expression were de-
termined at 0, 30, 60, 90, 120, 150, 180, and 210 min. Viability of cells
was estimated by ability to form colony-forming units (CFU) on solid
media. B. thuringiensis samples were boiled at 96 C for 20 min before
plating. The number of colonies emanating from spores or viable cells
were counted after 24 h of incubation. Each point represents a mean of
duplicate experiments using three diﬀerent dilutions.
2.4. Puriﬁcation of Cry1Ab-cter protein, antibody generation and
Western blot analysis
Sonication was used for cell disruption and inclusion bodies were
solubilized in buﬀer A (0.01 M Tris–HCl, 0.1 M Na2PO4, 6 M Urea,
pH 8). Supernatants were then loaded onto a Chelating Sepharose
column (Pharmacia Biotech, Sweden) and Cry1Ab C-terminal portion
was eluted using buﬀer A containing Imidazol 250 mM. The eluted
protein was dialyzed against 0.1 M Na2CO3/NaHCO3/0.1% of glyc-
erol, pH 9.6. Purity and integrity of the recombinant protein was an-
alyzed on SDS–PAGE [24]. Protein concentration was determined by
the Bradford method [25]. For immunization in rabbits, puriﬁed
Cry1Ab-C-terminal was administered subcutaneously in complete or
incomplete Freund’s adjuvants [26]. Speciﬁc polyclonal antibodies
were immunopuriﬁed using a Cry1Ab C-terminal Sepharose column.
Immunoreactivity and speciﬁcity of polyclonal antisera were measured
by ELISA in 96-well plates coated with 100 ll (10 lg/ml) of B. thur-
ingiensis HD73 Cry1Ac toxin or recombinant Cry1Ab C-terminal in
carbonate buﬀer, pH 9.6 [27]. This anti-serum did not cross-react with
the N-terminal part of the protoxin. Proteins were electro-transferred
from SDS–PAGE gels onto nitrocellulose membranes and exposed to
the generated Cry1Ab C-terminal-speciﬁc antiserum. Immune com-
plexes were detected using an ECL-Western blot kit (Amersham-
Pharmacia).
2.5. Protein analysis
Recombinant bacterial cells harboring each of the expression plas-
mids were grown in speciﬁc media with antibiotics. At regular time
intervals post-induction (0, 2, 4, 6, 10, 12 h), aliquots (30 ll) were taken
and mixed with 30 ll of SDS–PAGE loading buﬀer, then boiled for 5
min, cooled and spun down at 12 000 g for 10 min. The cleared su-
pernatants were analyzed on SDS–PAGE-10% and total protein pro-
ﬁles revealed with Coomassie brilliant blue.
2.6. Solubility analysis
E. coli cells were harvested 2 h after IPTG-induction from a 200-ml
culture, resuspended in 20 ml of TE 1 and disrupted by sonicating
twice in a Branson Sonicator 250. Inclusion bodies were collected by
centrifugation at 6000 g for 10 min. These inclusion bodies yielded
about 4 mg of recombinant protein per liter of culture. Isolated in-
clusion bodies (30 lg protein) were resuspended in 36 ll of universal
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mercaptoethanol. After overnight incubation, suspensions were cen-
trifuged, then supernatants and pellets were resolved by electrophoresis
on a 10% SDS–PAGE.
2.7. Calculations and statistics
Each value represents the mean of three independent experiments.
Maximal variation, expressed as a variation coeﬃcient, is given in the
legend where applicable.3. Results
3.1. Cry1Ab C-terminal crystal domain expression in E. coli
The C-terminal part of cry1Ab gene [encoded between P606-
E1156] was N-terminal fused to a 6-Histidine tag under the
control of the synthetic, IPTG-sensitive Ptac promoter. The
expected 65 kD recombinant protein was detectable as early as
60 min post-induction (Fig. 2A and B). This recombinant
protein was unstable after 12 h becoming undetectable there-
after (Fig. 2B), most likely by intracellular proteolysis. Fur-
thermore, the Cry1Ab C-terminal also formed inclusion
bodies, which resembled the bipyramidal crystal produced by
B. thuringiensis during sporulation (Fig. 2E). The identity of
these recombinant peptides was conﬁrmed by Western blot
using a previously generated anti Cry1Ab C-terminal rabbit
antiserum (data not shown).Fig. 2. Cry1Ab C-terminal crystal domain expression in E. coli cells. (A) Sho
the following proteins (encoding plasmids between parentheses): (1) Empty
(pMal-ter); (4) tCry1Ab (pUCK-19); (5) DomainIII-C-terminal (pCon-SP).
combinant proteins that were overexpressed were marked with arrows. (B) T
PAGE. Note that this expression fades after 16 h of induction. Time 0 corre
Respective growth curves and viability of E. coli transfected with one of the fo
pCons36 (Cry1Ab-C-terminal, -m-); pMal-ter (MBP-Cry1Ab-C-terminal, -.-
Cry1Ab C-terminal alone or fused to MBP protein was lethal for E. coli. All
colonies (CFU0) at the induction time (arrowhead). All standard errors of t
photograph of ‘‘ghost’’ E. coli cells containing the bipyramidal-like inclusion b
show the lethal eﬀect of Cry1Ab C-terminal expression (bottom left plate)
supplemented with or without IPTG. The empty vector pQE-30 was used aSince the expression of Cry1Ab C-terminal in E. coli was
fading with time, we checked toxicity of this protein to the host
bacteria. Temporal expression of Cry1Ab C-terminal showed a
lethal eﬀect on E. coli. After transcriptional induction with
IPTG, the growth of the cells bearing the pCons36 plasmid
(encoding for Cry1Ab C-terminal) was totally inhibited getting
the cultures into a forced stationary phase (2 h after induc-
tion), while the number of viable cells dropped dramatically
(Fig. 2C and D). Fusing the Cry1Ab C-terminal to a non-
speciﬁc peptide such as MBP did not reduce the toxicity.
However, either insertion of the whole insecticidal domain or
part of it (domain III encoded between R449 and P606) di-
minished such a lethal eﬀect. No toxicity was found upon
IPTG treatment in cells bearing empty vectors or expressing
the insecticidal portion alone. Similar observations were made
using solid media (Fig. 2F). It is noteworthy that puriﬁed
Cry1Ab C-terminal added to liquid media did not have any
inhibitory eﬀect on E. coli growth (data not shown), which
excludes any bystander eﬀect.3.2. Cry1Ab C-terminal crystal domain expression in
A. tumefaciens
To conﬁrm if Cry1Ab C-terminal portion has a similar toxic
eﬀect on other gram-negative bacteria, mbp-cry1Ab-cter gene
together with lacIq were inserted into the pCAMBIA 1301wn is the total protein proﬁles of IPTG-induced E. coli cells producing
vector (pQE-30); (2) Cry1Ab C-ter (pCon36); (3) MBP-Cry1Ab-Cter
Total protein lysates were resolved on a 10% SDS–PAGE. Only re-
emporal expression of Cry1Ab C-terminal in E. coli showed by SDS–
sponds to the time when the inducter (IPTG) was added. (C) and (D)
llowing plasmids: pQE 30 (empty vector, --); pOS4201 (Cry1Ab, --);
), pMAl-c (MBP, --) and pConsSP (DIII-cter, -n-). The expression of
values are expressed with respect to the absorbance (A0) or amount of
hree individual experiments were less than 30%. (E) Electronic micro-
odies formed by Cry1Ab C-terminal. (F) Representative experiment to
in E. coli cells grown on LB agar-based medium. These media were
s negative control.
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transformation. The recombinant protein was expressed eﬃ-
ciently in this bacterium after IPTG addition (Fig. 3C). The
expression of Cry1Ab-pMal-cter inhibited A. tumefaciens
growth and markedly aﬀected cell viability (Fig. 3A and B) in
both liquid and solid media (Fig. 3D), thus reproducing its
eﬀects on E. coli.
3.3. Cry1Ab C-terminal crystal domain expression in
B. thuringiensis
To ascertain whether the production of Cry1Ab C-terminal
is also toxic to its natural host B. thuringiensis, we clonedFig. 3. Cry1Ab C-terminal expression in A. tumefaciens cells. (A) and (B) Re
Cry1Ab MBP-C-terminal protein (pCAMBIA-C-ter, -.-). The control was
pression was also lethal to A. tumefaciens cells. IPTG-induction point was
periments were less than 25%. (C) SDS–PAGE analysis of Cry1Ab MBP-
produced in those cells after induction with IPTG (arrowhead). (D) Repre
terminal in A. tumefaciens cells was grown on LB agar-based medium (bottom
empty vector pCAMBIA 1301 was used as negative control.
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Fig. 4. Cry1Ab C-terminal expression in B. thuringiensis cells. (A) and (B) R
following recombinant protein: DIII-cter (pLBA SP, --); Cry1Ab (pLBA C
tox, -j-) and an empty vector (pTH304, -r-). Note that both Cry1Ab C-term
sporulation, sporulation generally starts 8–12 h after seeding. Standard errocry1Ab-cter gene, and a portion encoding the insecticidal do-
main only, under the control of the active Cry1Ac promoter
during sporulation (constructs outlined in Fig. 1). Both vectors
were able to inhibit B. thuringiensis growth in GYS sporulation
media, which usually occurs within the ﬁrst 10 h of culture.
Moreover, those cells were not able to produce viable spores.
In contrast, production of the whole protoxin containing both
the insecticidal and the C-terminal domains, did not lead to
any signs of toxicity (Fig. 4A and B). Toxicity was lost when
the insecticidal domain III was fused with the Cry1Ab C-ter-
minal. Also, no toxicity was seen when B. thuringiensis cells
were transfected with the empty vector pLBA 100.spective growth curves and viability of A. tumefaciens cells expressing
made of the empty vector pCAMBIA 1301 (--). Note that this ex-
mark with an arrowhead. Standard errors of the three individual ex-
C-terminal production in A. tumefaciens. This protein was eﬃciently
sentative experiment that shows the lethal eﬀect of Cry1Ab MBP C-
left plate). These media were supplemented with or without IPTG. The
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espective growth and viability curves of B. thuringiensis producing the
ry1Ab, --); Cry1Ab C-terminal (pLBA-ter, -m-), Cry1Ab-tox (pLBA-
inal and Cry1Ab N-terminal were highly toxic to B. thuringiensis after
rs of the three individual experiments were less than 35%.
Fig. 5. (A) Genetic constructs were used to determine the toxic region of Cry1Ab C-terminal to E. coli. (B) SDS–PAGE analysis of the expression of
pConsHindIII (lane 1) and pConsDHindIII (lane 3); the latter being the only portion that was eﬃciently produced. Empty vectors pQE-30 (lane 4)
and pQE-32 (lane 2) were used as negative controls. (C) and (D) Respective growth and viability curves of E. coli cells producing the following
recombinant peptides: with empty vector (pQE-30, --); Cry1Ab-cter (pCons36, -j-); Cry1Ab-D cter (pConsDHindIII, -n-) and Cry1Ab-cter-III
(pConsHindIII, -.-). Note that the expression of Cry1Ab C-terminal-HindIII was toxic to E. coli cells. The induction point was marked with an
arrowhead. Standard errors of the three individual experiments were less than 15%.
Fig. 6. pH–solubility of Cry1Ab inclusion bodies is not dependent on the C-terminal portion. Inclusion bodies were produced in E. coli were isolated
by diﬀerential centrifugation and incubated in diﬀerent pH buﬀers in presence or absence of b-mercaptoethanol (1% v/v). No C-terminal portion was
recovered in the soluble fractions.
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C-terminal domain
To locate the toxic region of the Cry1Ab C-terminal in E.
coli, we split this gene in two segments that encode for the
following two polypeptides: (i) a 37.2 kDa protein [from P606-
R914, consD HindIII], and (ii) the far C-terminal part of the
protoxin [from E915-E1156, cons HindIII] (Fig. 5A). Only this
ﬁrst part of the protein was eﬃciently produced, and showed
to be harmless to E. coli host cells. In contrast, the part en-
coded by ConsHindIII was produced in minute amounts and
was extremely toxic to the host (Fig. 5C and D).
3.5. Solubility of Cry1Ab C-terminal inclusion bodies
Bipyramidal inclusion bodies formed by the whole Cry1Ab
protoxin are known to have a peculiar solubility dependent onthe environment’s pH (solubilization generally occurring at
pH>9). Herein, we tested whether puriﬁed Cry1Ab C-termi-
nal inclusion bodies in E. coli are able to keep these solubility
properties. We found that Cry1Ab C-terminal inclusion bodies
are resistant to solubilization even at pH>9 (pH range 5–12)
in presence (Fig. 6) or absence (data not shown) of b-
mercaptoethanol as a reducing agent. Solubilization was only
possible with high concentrations of Urea (6 M).4. Discussion
The majority of Cry1A protoxins are composed of two
functional segments [9]: the protease-resistant core toxin and
the C-terminal portion whose function is not yet very well
R.I. Vazquez-Padron et al. / FEBS Letters 570 (2004) 30–36 35understood. Studies in the past focused on determining the
structure and mode of action of the insecticidal domain; only
few have addressed other roles of Cry1A C-terminal domains
besides crystal formation. Herein, we found that the N-ter-
minal portion corresponding to the active insecticidal toxin
fragment showed toxicity against the natural host B. thurin-
giensis but had none for the experimental E. coli recipient.
More importantly, we produced the Cry1Ab C-terminal do-
main in three diﬀerent bacterial hosts, and provided evidence
that it had a cryptic toxic property towards not only the nat-
ural host B. thuringiensis but also to experimental recipients
E. coli and A. tumefaciens as well. Hence, both parts of the
protoxin sitting on the same protein are necessary to evade this
eﬀect. Based on these ﬁndings, we postulate that a natural dot/
anti-dot relationship exists between the Cry1Ab two halves.
The putative requirement for the dot/anti-dot system within
the host may explain its high conservation among Cry
subfamilies.
This is the ﬁrst report that delineates another function for
the Cry1Ab C-terminal portion other than crystal formation.
From our ﬁndings, an important question arises on why other
Cry proteins lack the C-terminal domain from their protoxin
yet the latter are not toxic to their respective natural hosts.
Indeed this fragment is not present in Cry3A, Cry3B, Cry3Bb,
Cry3Ca, Cry2Aa, Cry2Ab, Cry2Ac, and Cry11Aa or is very
small in some other protoxins such as Cry1IA and Cry1Ib (75
residues) and Cry13A (111 residues) [10]. The answer may lie
in the extra-long N-terminal portions of the C-terminal-lack-
ing protoxins, which may confer both crystal forming and anti-
toxic (anti-dot) properties. Nonetheless, ﬁrm conclusions may
only be reached by generating mutants lacking those domains.
Besides having a toxic eﬀect to its natural host B. thuringi-
ensis, an equally important ﬁnding from this study is that
production of Cry1Ab C-terminal also showed toxicity for two
other gram-negative bacteria, namely E. coli and A. tumefac-
iens. Interestingly, Cry1Ab C terminal was produced promptly
in E. coli and lasted for 12 h even though cell viability dropped
quickly (100 min after induction). Moreover, electronic mi-
croscopy showed inclusion bodies inside ghost-like E. coli cells,
much like the ones observed during bacterial ghost production
by intracellular endonuclease expression [28]. The hypothesis
that Cry1Ab C-terminal expression initially inactivates bacte-
rial cell division but keeps the protein production and turnover
processes is in agreement with our ﬁndings.
Structurally, the Cry1 protoxins show a striking asymmetry
between the two halves in terms of cysteine composition and
physical properties. This raises the question as to whether these
two regions are functionally independent. Diﬀerential scanning
calorimetry studies demonstrated that part of the insecticidal
moiety of the protoxin must undergo conformational changes
on activation, to adopt a more thermostable structure [7]. As
we reported, the fact that domain III was enough to reduce the
C-terminal-mediated toxicity, may lead to think that this part
by itself could confer those conformational changes, mak-
ing the protoxin safer for the host bacterium undergoing
sporulation.
The Cry1A C-terminal domain by itself was able to form
inclusion bodies featuring the ones formed by the protoxin in
E. coli, whereas from our previous reports, we demonstrated
that the N-terminal domain alone produced a soluble protein
[23]. However, the solubility of the C-terminal was quite dif-
ferent from that of the whole protoxin. The C-terminal bodieswere unable to dissolve even at high pH values in presence or
absence of reducing agents. Those ﬁndings indicate that the
crystal formation and the peculiar solubility features of the
Cry1As are conferred by the structure of the protoxin where
both domains take crucial roles. The generation of a chimeric
protein by fusion of Cry3A (C-terminal lacking protoxin) to
the Cry1Ab C-terminal portion gave rise to insoluble inclusion
bodies in E. coli (data not shown). Thus, we propose that
Cry1As need their terminal portion to conserve the solubility
at high pH, as commonly found in lepidopteran midgut. This
study also supports the idea that both protoxin moieties are
required for proper folding needed for sequential protoxin
proteolysis leading to the N-terminal half to acquire its in-
secticidal function [7]. Interestingly, decades ago Holmes and
Monro [29], based on X-ray power diﬀraction of B. thuringi-
ensis crystals concluded that the protoxin was an elongated
molecule unlike the tertiary structure described for crystallized
N-terminal domain.
Finally, Cry1Ab protoxin contains a remarkably high
number of cysteine residues, 14 out of 16 being in the C-ter-
minal half, which makes the observed rapid refolding of this
region unusual. In the absence of reducing agents, cysteine-rich
proteins are known to commonly form incorrect disulﬁde
bridges [30]. A plausible explanation to this may be that thiol
groups located on the surfaces of the protoxin are able to form
symmetrical interchain disulphide bridges during crystal
formation.
In conclusion, toxicity associated with individual production
of the Cry1Ab halves (insecticidal N-terminal or C-terminal)
uncovers a cryptic endotoxicity to the natural host B. thurin-
giensis. Acquisition of this property also reveals a fail-safe
mechanism operating, protecting the host bacteria in a manner
much like a dot/anti-dot system. Furthermore, our ﬁndings
strongly support the assumption that B. thuringiensis Cry1A
protoxin insecticidal and crystal forming domains do not op-
erate independently, but rather have complementary roles for
proper crystal formation, solubility properties, and shielding
from endotoxicity.References
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